Literature DB >> 3924848

Distribution studies of 111In-oxine-labeled peritoneal mononuclear cells in tumor-bearing rats.

K Abreo, L M Lieberman, A V Moorthy.   

Abstract

We studied the distribution of 111In-labeled peritoneal mononuclear cells (PMC) in Sprague-Dawley rats with carcinosarcoma (CS) tumor. We obtained PMC from normal rats and rats pretreated with BCG or irradiated CS cells as antigenic stimulant. PMC were labeled in-vitro with 111In-oxine and transferred by tail-vein injection to rats bearing CS tumor. Twenty-four, 48 and 72 h after PMC transfer, we measured the accumulation of these cells in the CS tumor as a percentage of dose radioactivity per gram of tumor using an external gamma-ray camera. PMC from normal and BCG treated donor rats accumulated 0.4% and 0.46% dose per gram of CS tumor respectively. PMC from donor rats given killed CS cells accumulated significantly greater concentrations of 111In (0.79% dose per gram of CS tumor, P less than 0.025). Thus killed CS cells were able to sensitize the PMC of normal rats. 111In-oxine-labeling is an elegant procedure to study the distribution of mononuclear cells in tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924848     DOI: 10.1016/0047-0740(85)90013-0

Source DB:  PubMed          Journal:  Int J Nucl Med Biol        ISSN: 0047-0740


  2 in total

1.  Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles.

Authors:  Sungmin Kang; Ho Won Lee; Young Hyun Jeon; Thoudam Debraj Singh; Yun Ju Choi; Ji Young Park; Jun Sung Kim; Hyunseung Lee; Kwan Soo Hong; Inkyu Lee; Shin Young Jeong; Sang-Woo Lee; Jeoung-Hee Ha; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

2.  Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models.

Authors:  Wendy Bernhard; Kris Barreto; Ayman El-Sayed; John DeCoteau; C Ronald Geyer
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.